BDX vs PHGE · P/E 34, rev $21.84B vs P/E 0.0, rev $332.0K
Becton Dickinson and Company (BDX) versus Biomx Inc (PHGE) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Biomx Inc (PHGE) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported PHGE revenue for 2026-06-30 was $332.0K. Net income was -$3.8M. PHGE currently screens at market cap $11.5M and trailing P/E 0.0.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. PHGE currently screens at market cap $11.5M and trailing P/E 0.0.
Not investment advice. Open the BDX and PHGE stock pages for the full models.
Not investment advice.